Glucagon-like Peptide-1 Receptor Agonists: Additional Improvement of Erectile Dysfunction in Type 2 Diabetes

Current Vascular Pharmacology · Published 2025-06-26 · DOI 10.2174/0115701611415013250616111421

Authors being retrieved — see the publisher record. https://doi.org/10.2174/0115701611415013250616111421

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Is the Cardiovascular Risk Increased in Patients with Isolated SystolicHypertension and Anemia? · Current Vascular Pharmacology · 2026 · Same journal
Comparison of Clinical Outcomes between Newly Diagnosed and Pre-Existing Diabetes Mellitus Patients after Acute Coronary Syndrome · Current Vascular Pharmacology · 2025 · Same journal
Clinical Predictors of Warfarin Response Among Patients with Atrial Fibrillation: Evidence from the Middle Eastern JoFib Study · Current Vascular Pharmacology · 2025 · Same journal
Postprandial Triglycerides and Residual Cardiovascular Risk: RethinkingLipid-Lowering Strategies · Current Vascular Pharmacology · 2026 · Same journal
PCSK9: Its Role in Lipid Metabolism and as a Novel Target for the Treatment of Metabolic Kidney Disease · Current Vascular Pharmacology · 2025 · Same journal
Advances in Drug-Eluting Angioplasty Balloon Coatings, Clinical Implications and Future Directions: A Mini Review · Current Vascular Pharmacology · 2025 · Same journal
Cardiovascular Risks of Electronic Cigarettes: Mechanisms, Evidence, and Research Gaps · Current Vascular Pharmacology · 2026 · Same journal
Significant Stagnancy in the Search and Use of New Antiarrhythmic Agents With Some Recent Beams of Hope · Current Vascular Pharmacology · 2025 · Same journal
Effect of Statins on Postprandial Hypertriglyceridemia: Editorial forHellenic Postprandial Lipemia Study (HPLS), A Prospective Cohort Trial · Current Vascular Pharmacology · 2026 · Same journal
Association between Statin use and Abdominal Aortic Calcification in Male, Non-diabetic Elderly · Current Vascular Pharmacology · 2025 · Same journal